Related Experiment Video
Updated: Aug 26, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Insights
Essential arterial hypertension significantly impacts cardiovascular health, increasing risks. Urapidil is an antihypertensive drug that can be used in treatment to reduce these negative consequences.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Essential arterial hypertension, while often asymptomatic in daily life, poses significant risks for cardiovascular morbidity and mortality.
- The severity of hypertension, patient age, and comorbidities are key factors influencing cardiovascular outcomes.
Purpose of the Study:
- To describe the antihypertensive drug urapidil.
- To highlight the importance of reducing blood pressure and overall cardiovascular risk in hypertensive patients.
Main Methods:
- This article provides a description of the drug urapidil.
- Literature review on the role of urapidil in managing hypertension.
Main Results:
- Urapidil is presented as a potential pharmacotherapeutic option for managing essential arterial hypertension.
- The article emphasizes the broader goal of therapy beyond blood pressure reduction to mitigate cardiovascular consequences.
Conclusions:
- Urapidil can be utilized in the pharmacotherapy of essential arterial hypertension.
- Effective hypertension management aims to reduce both blood pressure and associated cardiovascular risks, including morbidity and mortality.
Abstract:
Essential arterial hypertension is not a disease that would significantly adversely affect patients in their daily activities. At least mostly. Nonetheless, it has a significant negative impact on cardiovascular morbidity and mortality. The tight correlation with the degree of hypertension, the patients age and, of course, commorbidities and cardiovascular risk factors is obvious. Therefore, the goal of hypertensive therapy is not only to try to achieve optimal reduction of blood pressure, but in a broader sense to reduce the risk of the just mentioned consequences, i.e. to reduce morbidity and reduce mortality. The antihypertensive drug urapidil can also be used in pharmacotherapy, the brief description of which is the subject of this article.
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Thiazide-Class Diuretics
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

